Acute Kidney Injury
Acute Kidney Injury Market

Acute Renal Failure (ARF), which is now known as Acute Kidney Injury (AKI), is characterized by azotemia that progresses over several hours or days, with or without oliguria. ARF is commonly defined as an abrupt decline in renal function, clinically manifesting as an acute reversible increase in nitrogen waste products measured by blood urea nitrogen (BUN) and serum creatinine levels over hours to weeks. The disease leads to an abrupt loss of kidney function, leading to the retention of waste products, electrolyte disturbances, and volume status changes.


Acute Kidney Injury Epidemiological Segmentation 

The Epidemiological Segmentation of Acute Kidney Injury in 7MM from 2017 to 2030 is segmented as:- 

  • Total Incident Patient Population of AKI
  • Discharge Diagnosed Cases of AKI
  • Stage wise Discharged Diagnosed cases of AKI
  • Risk Factor Associated AKI Cases
  • Renal Transplantation Associated Delayed Graft Function Cases


Acute Kidney Injury Epidemiology 

  • The highest incident cases of AKI were recorded in the United States in 2017 were 895,078 
  • Among the EU5 countries, Germany had the highest AKI diagnosed cases in 2017 were 82,902 
  • Acute Kidney Injury affects males and females equally


Acute Kidney Injury Market

The Market Size of Acute Kidney Injury in the United States in 2017 was USD 2,907 Million 


Acute Kidney Injury Market Drivers

  • Robust Pipeline Activity
  • Increased incidence of hospitalization
  • Reimbursement policies


Acute Kidney Injury Market Barriers

  • Disease burden
  • Morbidity/ mortality
  • Disease management & treatment


Acute Kidney Injury Emerging Drugs

The emerging drugs of the Acute Kidney Injury market are 

  • EA-230
  • bRESCAP
  • ANG-3777  
  • QPI-1002
  • recAP
  • Reltecimod
  • ASP1128
  • Levosimendan 
  • MB-102
  • Ruconest

And many others.  


Acute Kidney Injury Key Players

The key players in the Acute Kidney Injury market are

  • Exponential Biotherapies
  • Alloksys
  • Angion Biomedica
  • Quark Pharmaceuticals
  • AM Pharma
  • AtoxBio
  • Astellas Pharma
  • Orion Pharma
  • MediBeacon
  • Pharming Technologies

And many others.